Holland Capital invests in HuisartsenHulp and strengthens its position in primary care with CareAbout
Amsterdam – March 12th, 2026 – Holland Capital has invested in HuisartsenHulp and CareAbout, both specialists in workforce solutions for primary care. The combination creates an organisation that broadly supports general practitioner practices, GP out-of-hours services, pharmacies and other primary care providers with both temporary and structural staffing needs and supporting services.
Rising structural demand for primary care
Demand for primary care in the Netherlands continues to rise due to demographic developments, the decentralisation of healthcare, and increasing healthcare needs. At the same time, the healthcare labour market remains under significant pressure.
HuisartsenHulp and CareAbout respond to this by supporting healthcare providers quickly, effectively and with high-quality solutions to address capacity constraints. The combined organisation thereby contributes to maintaining continuity of care. HuisartsenHulp primarily focuses on safeguarding continuity within GP practices and healthcare centres through its proprietary software platform, while CareAbout specialises in long-term staffing solutions for, among others, pharmacies and GP practices. Together, they offer complementary services with nationwide coverage across primary care.
Joining forces
By bringing together HuisartsenHulp and CareAbout, a combined organisation is created that focuses on providing flexible, long-term and supportive solutions within primary care. The complementary nature of their target groups, services and networks creates a nationwide platform that supports GP practices and pharmacies in addressing both temporary and structural capacity challenges.
Hans Pruis, CEO of HuisartsenHulp: “With the support of Holland Capital and the collaboration with CareAbout, we can further professionalise and scale our services to better support healthcare providers in a challenging labour market.”
Timothy Hoolhorst, CEO of CareAbout: “This collaboration enables us to further strengthen our expertise and expand our services for both healthcare professionals and clients.”
Philip Wilms, Investment Director at Holland Capital: “The combination of HuisartsenHulp and CareAbout fits well with our investment strategy and sits at the intersection of our focus areas Technology and Healthcare. The combined organisation contributes structurally to the continuity of care in the Netherlands by not merely shifting scarcity, but by adding new capacity.”
About HuisartsenHulp
HuisartsenHulp is a specialised intermediary in primary care and supports GP practices, healthcare centres and GP out-of-hours services with temporary and structural staffing solutions. The organisation has a nationwide network of healthcare professionals and enables rapid deployment to address urgent capacity challenges. In addition, HuisartsenHulp operates its own digital platform that efficiently matches supply and demand and further optimises the deployment of healthcare professionals within primary care.
About CareAbout
CareAbout operates in general practice and pharmacy care, connecting healthcare professionals with GP practices and pharmacies. The organisation offers various contract models, including secondment, flexible contracts and self-employed arrangements, and focuses on sustainable matches and career guidance.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare and Technology sector.
Holland Venture en BOM investeren in CytoSMART: digitale microscopie in the cloud
Amsterdam/Tilburg, 13 juni 2016 - Investeringsmaatschappij Holland Venture investeert samen met de Brabantse Ontwikkelings Maatschappij (BOM) in CytoSMART Technologies. CytoSMART, opgericht in 2012 onder de naam CytoMATE, is een spin-off van de TU/e. Het bedrijf...
Holland Venture and BOM invest in CytoSMART: digital microscopic imaging in the cloud
Amsterdam/Tilburg, 13 June 2016 - Private equity firm Holland Venture and the Brabant Development Agency (BOM) are together investing in CytoSMART Technologies. Founded in 2012 under the name CytoMATE, CytoSMART is a spin-off of Eindhoven University of Technology...
Humeca opent officieel zusterbedrijf Humeca, Inc. in de Verenigde Staten
De opening volgt op een gestage groei van de vraag en het aanbod van hun producten wereldwijd en stelt Humeca in staat om hun distributienetwerk in de Verenigde Staten uit te breiden. De huidtransplantatie producten zijn levensreddend voor de behandeling van...
Humeca officially launches sister company Humeca, Inc. in the USA
Amsterdam, 12 februari 2016 - The launch follows a steady growth in demand and supply of their products worldwide and enables Humeca to expand their distribution network in the United States. The skin grafting products are life-saving for the treatment of burn...
Holland Venture investeert fors in groei marketingtechnologiebedrijf Relay42
Amsterdam, 8 december 2015 – Investeringsmaatschappij Holland Venture en de voormalige topmanager van Booking.com investeren gezamenlijk enkele miljoenen in de Nederlandse datamanagementspecialist Relay42. Met het innovatieve datamanagementplatform van Relay42 kunnen...
Holland Venture provides substantial investment to marketing technology company Relay42
Amsterdam, December 8th 2015 – Holland Venture and a former Board Executive of Booking.com have invested several millions of euros in the Dutch data management specialist Relay42. Marketers use Relay42’s innovative data management platform to coordinate the customer...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl